Literature DB >> 3038125

5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage.

B J Dull, K Salata, A Van Langenhove, P Goldman.   

Abstract

It has been postulated that oxygen radicals may play a role in the pathogenesis of inflammatory bowel disease. If so, then a drug like 5-aminosalicylate (5-ASA), which is used to treat such diseases, might work by interacting with oxygen-derived species. We found that activated mononuclear cells and activated granulocytes, as well as the products of the Fenton reaction, transformed [14C]5-ASA to a number of metabolites, among which we have characterized salicylate and gentisate. We also found that the lethal effect on cultured Chinese hamster ovary cells of adding either superoxide radical or hydrogen peroxide, components of the respiratory burst of activated white blood cells, was diminished by the addition of 100 micrograms/ml (0.65 mM) of 5-ASA. Thus, we have demonstrated that 5-ASA was oxidized by the oxidative burst of white blood cells and that 5-ASA protected cells from damage by oxygen-derived species, two findings which may offer an explanation for the role of 5-ASA in the treatment of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038125     DOI: 10.1016/0006-2952(87)90518-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

Review 1.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 2.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 3.  Radical induction theory of ulcerative colitis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

Review 4.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

5.  5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells.

Authors:  S M McKenzie; W F Doe; G D Buffinton
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 6.  Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation.

Authors:  T Yamada; M B Grisham
Journal:  Klin Wochenschr       Date:  1991-12-15

7.  Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils.

Authors:  J G Williams; M B Hallett
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

8.  Reaction of 5-aminosalicylic acid with peroxyl radicals: protection and recovery by ascorbic acid and amino acids.

Authors:  Camilo López-Alarcón; Claudia Rocco; Eduardo Lissi; Catalina Carrasco; J Arturo Squella; Luis Nuñez-Vergara; Hernan Speisky
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

9.  Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.

Authors:  S M Greenfield; N A Punchard; R P Thompson
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

Authors:  T P Mulder; H W Verspaget; A R Janssens; P A de Bruin; A S Peña; C B Lamers
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.